130800-83-8

Basic information

• Product Name: 1-(BROMOMETHYL)-2,3,5-TRICHLOROBENZENE
• Synonyms: 1-(BROMOMETHYL)-2,3,5-TRICHLOROBENZENE
• CAS NO: 130800-83-8
• Molecular Formula: C₇H₄BrCl₃
• Molecular Weight: 274.37
• Mol File: 130800-83-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 291.6°Cat760mmHg
• Flash Point: 146.8°C
• Appearance: /
• Density: 1.772g/cm³
• Vapor Pressure: 0.00336mmHg at 25°C
• Refractive Index: 1.608
• CAS DataBase Reference: 1-(BROMOMETHYL)-2,3,5-TRICHLOROBENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(BROMOMETHYL)-2,3,5-TRICHLOROBENZENE(130800-83-8)
• EPA Substance Registry System: 1-(BROMOMETHYL)-2,3,5-TRICHLOROBENZENE(130800-83-8)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 130800-83-8(Hazardous Substances Data)

Usage

General Description

1-(Bromomethyl)-2,3,5-trichlorobenzene is a chemical compound with the molecular formula C7H4BrCl3. It is a colorless liquid with a molecular weight of 259.37 g/mol. 1-(BROMOMETHYL)-2,3,5-TRICHLOROBENZENE is widely used as a pesticide and insecticide due to its effectiveness in controlling various pests and insects. It is also used in the manufacturing of various products such as plastics, solvents, and other industrial chemicals. However,

InChI:InChI=1/C7H4BrCl3/c8-3-4-1-5(9)2-6(10)7(4)11/h1-2H,3H2

Upstream product

• 4681-17-8 2,3,5-trichlorophenylmethanol 

Downstream Products

• 4681-16-7 2,3,5-trichlorophenylacetonitrile 

Relevant articles and documents

Herbicidal 3-(substituted-benzyl)-1-methyl-6-trifluoromethyluracils

Herbicidal 3-(substituted-benzyl)-1-methyl-6-trifluoromethyluracils, compositions containing them, and methods of using them to control undesired plant growth, including use to control weeds in certain crops, are disclosed. The herbicidal compounds of the present invention are defined by the following generic structure: STR1 in which V is hydrogen, halogen, nitro, amino, alkoxy, alkyl, cyano, phenyl, alkylcarbonylamino, alkylsulfinyl, or haloalkyl; W is hydrogen, halogen, alkyl, alkoxy, alkylaminocarbonyl, propargyloxy, cyano, nitro, benzoyl, aminooxycarbonyl, alkylsulfonyl, alkoxyiminoalkyl, alkylthio or alkylsulfinyl; X is hydrogen, chlorine, alkoxy, nitro, or amino; Y is hydrogen, halogen, alkyl, haloalkyl, alkoxy, haloalkoxy, alkoxyalkyl, alkylthio, alkylthioalkyl, alkenyl, acyl, epoxyalkyl, cyano, alkylaminocarbonyl, carboxy, formyl, hydroxy, hydroxyalkyl, haloalkylsulfonyloxy, benzoyl, aminooxycarbonyl, alkoxycarbonyl, propargyloxy, alkylsulfonyl, alkylsulfinyl, alkoxyiminoalkyl, or dialkylaminocarbonylthio; X and Y taken together are --OCH2 O-- or --OC(CH3)2 O--, where halogen is bromine, chlorine, fluorine, or iodine, and each aliphatic moiety has one to three carbon atoms.

Pharmacologically active CNS compound

The invention provides a series of compounds of formula (I) and salts thereof, wherein for example,R1 and R2, which may be the same or different each represent -NR13R14 where R13 and R14 may each independently represent hydrogen or alkyl or, taken together with the nitrogen atom to which they are attached form a heterocyclic ring, optionally substituted by one or more alkyl or arylalkyl groups and optionally containing a further heteroatom;, R3 is hydrogen, haloalkyl, alkoxymethyl or alkyl;, R4 is hydrogen, nitro or halo;, R5 is hydrogen or halo;, R6 is hydrogen, halo, nitro, amino, alkylamino or dialkylamino;, R7 is hydrogen or halo;, R8 is hydrogen or halo; The compounds may be used for the treatment or prophylaxis of a neurodegenerative or other neurological disorder of the CNS, the aetiology or which includes excessive release of the neurotransmitter glutamate.